Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lethal Alleles02:41

Lethal Alleles

19.2K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
19.2K
Pleiotropy01:33

Pleiotropy

44.0K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
44.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

997
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
997
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
ATP Synthase: Structure01:18

ATP Synthase: Structure

17.1K
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
17.1K
Incomplete Dominance01:43

Incomplete Dominance

32.3K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
32.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Prodromal Synucleinopathy Rating Scale: An Assessment in Patients With REM Sleep Behavior Disorder.

Neurology·2026
Same author

The North American Prodromal Synucleinopathy study: protocol for a multi-site, longitudinal, observational study of idiopathic/isolated rapid eye movement sleep behavior disorder.

Sleep advances : a journal of the Sleep Research Society·2026
Same author

Expert-level probabilistic breathing event detector informs phenotyping of sleep apnea.

Nature communications·2026
Same author

Can Low Cortisol Predict Long COVID? A Controversial Issue.

Biomedicines·2025
Same author

A Multidimensional Assessment of Sleep Disorders in Long COVID Using the Alliance Sleep Questionnaire.

Healthcare (Basel, Switzerland)·2025
Same author

CAISR: achieving human-level performance in automated sleep analysis across all clinical sleep metrics.

Sleep·2025
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Related Experiment Video

Updated: Mar 22, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.8K

Kleine-Levin Syndrome.

Oliver Sum-Ping1, Christian Guilleminault2

  • 1Stanford University Sleep Medicine Division, Stanford Outpatient Medical Center, Redwood City, CA, USA.

Current Treatment Options in Neurology
|April 14, 2016
PubMed
Summary
This summary is machine-generated.

Kleine-Levin Syndrome (KLS) is often misdiagnosed, requiring thorough clinical evaluation. Supportive care, trigger avoidance, and regular sleep are key, with medications considered for severe symptoms.

Keywords:
HyperphagiaHypersexualityHypersomniaHypocretinKleine-Levin syndromeLithium

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.5K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K

Related Experiment Videos

Last Updated: Mar 22, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.8K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.5K
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K

Area of Science:

  • Neurology
  • Sleep Medicine
  • Rare Diseases

Background:

  • Kleine-Levin Syndrome (KLS) is frequently under-recognized and misdiagnosed.
  • Accurate diagnosis is crucial for effective management and patient support.

Purpose of the Study:

  • To outline diagnostic criteria and management strategies for Kleine-Levin Syndrome.
  • To emphasize the importance of supportive care and trigger avoidance in KLS patients.

Main Methods:

  • Clinical evaluation including detailed history and neurological/psychiatric examination.
  • Ancillary studies such as polysomnography (PSG), EEG, neuroimaging, and laboratory tests to exclude differential diagnoses.
  • Review of current literature and clinical guidelines for KLS management.

Main Results:

  • Diagnosis relies on clinical presentation, family history, and exclusion of other conditions.
  • Supportive care, patient/family education, and caregiver supervision are foundational.
  • Trigger avoidance (alcohol, infection) and sleep-wake cycle regulation are recommended between episodes.

Conclusions:

  • Early recognition and accurate diagnosis of KLS are essential.
  • A multidisciplinary approach focusing on supportive care and trigger management improves outcomes.
  • Pharmacological interventions, including lithium for prophylaxis, may be considered in severe or frequent KLS episodes.